Michael is an associate in the life sciences group. He has been a strategy consultant for biopharma and medical device clients and worked with a Dana Farber Cancer Institute spin-out focused on hematologic malignancies. He led teams of volunteer consultants on projects for six Boston area non-profit organizations, and he completed four years of HIV vaccine research.
